deltatrials
Completed NA INTERVENTIONAL 2-arm NCT04660227

Exercise Training in Pediatric-Onset Multiple Sclerosis Patients

Effectiveness of Exercise Training in Pediatric-Onset Multiple Sclerosis Patients

Sponsor: Istanbul University - Cerrahpasa

Updated 9 times since 2021 Last updated: May 17, 2023 Started: Nov 23, 2020 Primary completion: Nov 25, 2021 Completion: Jan 1, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Pediatric Multiple Sclerosis and is currently completed. Istanbul University - Cerrahpasa leads this study, which shows 9 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotRecruiting~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Feb 2023 · 14 months · monthly snapshotRecruiting~Feb 2023 – ~Jun 2023 · 4 months · monthly snapshot~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – ~Sep 2025 · 9 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Dec 2024 — Sep 2025 [monthly]

    Completed NA

  3. Sep 2024 — Dec 2024 [monthly]

    Completed NA

  4. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  5. Jun 2023 — Jul 2024 [monthly]

    Completed NA

    Status: RecruitingCompleted

Show 4 earlier versions
  1. Feb 2023 — Jun 2023 [monthly]

    Recruiting NA

  2. Dec 2021 — Feb 2023 [monthly]

    Recruiting NA

  3. Sep 2021 — Dec 2021 [monthly]

    Recruiting NA

  4. Jan 2021 — Sep 2021 [monthly]

    Recruiting NA

    First recorded

Nov 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Istanbul University - Cerrahpasa
Data source: Istanbul University - Cerrahpasa

For direct contact, visit the study record on ClinicalTrials.gov .